www.fdanews.com/articles/197986-uk-launches-new-trial-platform-to-accelerate-covid-19-treatments
UK Launches New Trial Platform to Accelerate COVID-19 Treatments
July 9, 2020
The UK has launched a new clinical trial platform aimed at accelerating the development of COVID-19 treatments.
The AGILE initiative will test promising treatments in COVID-19 patients to see if they should be fast-tracked to large-scale trials. The trial platform was created by the University of Liverpool’s School of Tropical Medicine and the Southampton Clinical Trials Unit.
Ridgeback Biotherapeutics’ investigational antiviral EIDD-2801 will be the first treatment evaluated.